You just read:

MabVax Therapeutics Signs Research Agreement with Memorial Sloan Kettering Cancer Center to Develop Novel CAR T-Cell Based Anti-Cancer Immunotherapies for Treatment of Pancreatic and Small Cell Lung Cancers

News provided by

MabVax Therapeutics Holdings, Inc.

May 31, 2017, 07:05 ET